A prospective study of 1,755 patients demonstrated significantly higher serum levels of TNF-α, IL-6, and CRP in COPD patients compared to healthy controls, with longitudinal data revealing strong correlations between these inflammatory markers and frequency of exacerbations, degree of pulmonary function impairment, and mortality rates (29). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.